A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

NCT06803680 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Metastatic Solid Tumor

Interventions

DRUG: BGB-B455
DRUG: Chemotherapy

Sponsor

BeiGene